definiens: ) as of June 1, 2002 ( the ) and the Parties now wish to reedefine the terms governing their relationshipby entering into this Agreement;WHEREAS, MSD and RTI each desire that RTI process and produce certain human specialty allograft tissue listed inSchedule 2.1 attached hereto ( the ) and paste products containing demineralized bone, gelatin, andparticulate mineral ( ) including but not limited to cortical and/or cancellous chips listed in Schedule 2.1attached hereto, and MSD desires to distribute such Specialty Allografts and Bone Paste in accordance with the terms andconditions contained herein;WHEREAS, MSD desires to obtain a license from RTI to market, promote and distribute Specialty Allografts and BonePaste ; andWHEREAS, the Parties desire to work together to develop new technology and products for use in medical procedures;NOW, THEREFORE, in consideration of the mutual covenants and agreements set forth below, the Parties herebyrepresent, covenant and agree as follows : Page 4ARTICLE IAMENDMENT AND TERMINATION OF ORIGINAL AGREEMENTS AND 2002 AGREEMENT1.1 Amendment . In order to facilitate continued service to patients and efficient use of human tissue, prior toNovember 1, 2002, ( the ) the Parties continued to operate under the Original Agreements and agreed asfollows:(a ) Management Services Fee . Beginning on the Original Effective Date and ending on the day immediately priorto the Implementation Date, ( i ) with respect to UFTB Allografts, the Management Services Fee ( as such terms are definedin the 1996 Agreement ) was [ # # # ] % ) and ( ii ) with respect to UFTB Paste Products, the Management Services Fee ( as suchterms are defined in the 1998 Agreement ) was [ # # # ]